These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 24878054

  • 1. Relationship between final height and health outcomes in adults with congenital adrenal hyperplasia: United Kingdom congenital adrenal hyperplasia adult study executive (CaHASE).
    Han TS, Conway GS, Willis DS, Krone N, Rees DA, Stimson RH, Arlt W, Walker BR, Ross RJ, United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE).
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1547-55. PubMed ID: 24878054
    [Abstract] [Full Text] [Related]

  • 2. Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE).
    Han TS, Krone N, Willis DS, Conway GS, Hahner S, Rees DA, Stimson RH, Walker BR, Arlt W, Ross RJ, United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE).
    Eur J Endocrinol; 2013 Jun; 168(6):887-93. PubMed ID: 23520247
    [Abstract] [Full Text] [Related]

  • 3. Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort.
    Krone N, Rose IT, Willis DS, Hodson J, Wild SH, Doherty EJ, Hahner S, Parajes S, Stimson RH, Han TS, Carroll PV, Conway GS, Walker BR, MacDonald F, Ross RJ, Arlt W, United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE).
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E346-54. PubMed ID: 23337727
    [Abstract] [Full Text] [Related]

  • 4. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
    Pijnenburg-Kleizen KJ, Thomas CMG, Otten BJ, Roeleveld N, Claahsen-van der Grinten HL.
    J Pediatr Endocrinol Metab; 2019 Oct 25; 32(10):1055-1063. PubMed ID: 31573958
    [Abstract] [Full Text] [Related]

  • 5. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
    Manoli I, Kanaka-Gantenbein Ch, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C.
    Clin Endocrinol (Oxf); 2002 Nov 25; 57(5):669-76. PubMed ID: 12390343
    [Abstract] [Full Text] [Related]

  • 6. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: final height in 27 patients with the classical form].
    Lemos-Marini SH, Guerra-Júnior G, Morcillo AM, Baptista MT, Silva LO, Maciel-Guerra AT.
    Arq Bras Endocrinol Metabol; 2005 Dec 25; 49(6):902-7. PubMed ID: 16544012
    [Abstract] [Full Text] [Related]

  • 7. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
    Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP.
    J Clin Endocrinol Metab; 2007 May 25; 92(5):1635-9. PubMed ID: 17299071
    [Abstract] [Full Text] [Related]

  • 8. Growth and development in children with classic congenital adrenal hyperplasia.
    Bonfig W.
    Curr Opin Endocrinol Diabetes Obes; 2017 Feb 25; 24(1):39-42. PubMed ID: 27898585
    [Abstract] [Full Text] [Related]

  • 9. Clinical review: Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis.
    Muthusamy K, Elamin MB, Smushkin G, Murad MH, Lampropulos JF, Elamin KB, Abu Elnour NO, Gallegos-Orozco JF, Fatourechi MM, Agrwal N, Lane MA, Albuquerque FN, Erwin PJ, Montori VM.
    J Clin Endocrinol Metab; 2010 Sep 25; 95(9):4161-72. PubMed ID: 20823467
    [Abstract] [Full Text] [Related]

  • 10. CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency.
    Balsamo A, Cicognani A, Baldazzi L, Barbaro M, Baronio F, Gennari M, Bal M, Cassio A, Kontaxaki K, Cacciari E.
    J Clin Endocrinol Metab; 2003 Dec 25; 88(12):5680-8. PubMed ID: 14671153
    [Abstract] [Full Text] [Related]

  • 11. Final height of patients with classical congenital adrenal hyperplasia.
    Aycan Z, Akbuğa S, Cetinkaya E, Ocal G, Berberoğlu M, Evliyaoğlu O, Adiyaman P.
    Turk J Pediatr; 2009 Dec 25; 51(6):539-44. PubMed ID: 20196386
    [Abstract] [Full Text] [Related]

  • 12. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
    Bomberg EM, Addo OY, Kyllo J, Gonzalez-Bolanos MT, Ltief AM, Pittock S, Himes JH, Miller BS, Sarafoglou K.
    J Pediatr; 2015 Mar 25; 166(3):743-50. PubMed ID: 25557963
    [Abstract] [Full Text] [Related]

  • 13. Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience.
    Premawardhana LD, Hughes IA, Read GF, Scanlon MF.
    Clin Endocrinol (Oxf); 1997 Mar 25; 46(3):327-32. PubMed ID: 9156043
    [Abstract] [Full Text] [Related]

  • 14. Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia.
    Schernthaner-Reiter MH, Baumgartner-Parzer S, Egarter HC, Krebs M, Kautzky-Willer A, Kirchheiner K, Luger A, Bayerle-Eder M.
    J Sex Med; 2019 Oct 25; 16(10):1529-1540. PubMed ID: 31447379
    [Abstract] [Full Text] [Related]

  • 15. Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients.
    Arlt W, Willis DS, Wild SH, Krone N, Doherty EJ, Hahner S, Han TS, Carroll PV, Conway GS, Rees DA, Stimson RH, Walker BR, Connell JM, Ross RJ, United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE).
    J Clin Endocrinol Metab; 2010 Nov 25; 95(11):5110-21. PubMed ID: 20719839
    [Abstract] [Full Text] [Related]

  • 16. Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty.
    Stikkelbroeck NM, Van't Hof-Grootenboer BA, Hermus AR, Otten BJ, Van't Hof MA.
    J Clin Endocrinol Metab; 2003 Aug 25; 88(8):3525-30. PubMed ID: 12915631
    [Abstract] [Full Text] [Related]

  • 17. Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China.
    Juan L, Huamei M, Zhe S, Yanhong L, Hongshan C, Qiuli C, Jun Z, Song G, Minlian D.
    J Pediatr Endocrinol Metab; 2016 Jul 01; 29(7):841-8. PubMed ID: 27054598
    [Abstract] [Full Text] [Related]

  • 18. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
    Hargitai G, Sólyom J, Battelino T, Lebl J, Pribilincová Z, Hauspie R, Kovács J, Waldhauser F, Frisch H, MEWPE-CAH Study Group.
    Horm Res; 2001 Jul 01; 55(4):161-71. PubMed ID: 11598369
    [Abstract] [Full Text] [Related]

  • 19. Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: the Leipzig experience.
    Hoepffner W, Kaufhold A, Willgerodt H, Keller E.
    Horm Res; 2008 Jul 01; 70(1):42-50. PubMed ID: 18493149
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia.
    Torky A, Sinaii N, Jha S, Desai J, El-Maouche D, Mallappa A, Merke DP.
    J Clin Endocrinol Metab; 2021 Nov 19; 106(12):e5247-e5257. PubMed ID: 33677504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.